X0508 4 2025-11-12 0001671858 ARS Pharmaceuticals, Inc. SPRY 0001951238 Chakma Justin C/O ARS PHARMACEUTICALS, INC. 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 false true false false Chief Business Officer 0 Common Stock 2025-11-12 4 M 0 30000 0.84 A 166380 D Common Stock 2025-11-12 4 S 0 30000 8.9119 D 136380 D Common Stock 2025-11-12 4 S 0 136380 8.8634 D 0 D Stock Option (Right to Buy) 0.84 2025-11-12 4 M 0 30000 0 D 2029-07-04 Common Stock 30000 89047 D The weighted average sale price for the transaction reported was $8.9119, and the range of prices was between $8.87 and $8.97. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. The weighted average sale price for the transaction reported was $8.8634, and the range of prices was between $8.62 and $9.04. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Immediately exercisable. /s/ Kathleen Scott, Attorney-in-Fact 2025-11-14